The current invention is in the field of molecular biology/pharmacology and provides novel 3-oxabicyclo [3.3.1] nonene compounds and derivatives that modulate the effects of the classical estrogen receptors alpha and beta (ERalpha and ERbeta) with little to no biological or physiological effects on the G protein-coupled estrogen receptor GPER (also known as GPR30). These compounds may function as agonists and/or antagonists of one or more of the disclosed classical estrogen receptors.
                            当前的发明属于
分子生物学/药理学领域,提供了一种新颖的3-氧杂双环[3.3.1]
壬烯化合物及其衍
生物,能够调节经典
雌激素受体α和β(ERα和ERβ)的效应,对G蛋白偶联
雌激素受体GPER(也称为GPR30)几乎没有
生物学或生理效应。这些化合物可能作为所披露的一个或多个经典
雌激素受体的激动剂和/或拮抗剂。